PHI with Neurinoma
How does this condition affect your private health insurance?
A neurinoma, also known as a schwannoma, is a benign, slow-growing tumor originating from the Schwann cells surrounding nerves. While non-cancerous, its growth can compress the affected nerve or adjacent structures, leading to diverse symptoms. Commonly found on the vestibular nerve (acoustic neuroma), it can cause hearing loss, tinnitus, and balance issues. Other locations include spinal or peripheral nerves, manifesting as pain, weakness, or sensory changes. Diagnosis involves imaging like MRI. Treatment typically includes surgical removal or stereotactic radiosurgery, chosen based on tumor size, location, and patient health. Early intervention is crucial to preserve nerve function and prevent significant neurological deficits.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Months to several years, as symptoms gradually worsen
Duration of Illness (Lifetime)
Chronic, progressive condition if untreated; post-treatment, long-term monitoring may be needed
Cost of Treatment (Initial)
High (tens of thousands to hundreds of thousands of USD for surgery/radiation, plus diagnostics and follow-up)
Cost of Treatment (Lifetime)
High (initial treatment cost plus long-term monitoring, potential for rehabilitation, and management of residual symptoms or recurrence)
Mortality Rate
Very low, primarily associated with surgical complications for critical locations or untreated large tumors causing brainstem compression
Risk of Secondary Damages
High (e.g., hearing loss, facial paralysis, balance issues, pain, sensory deficits, depending on nerve affected)
Probability of Full Recovery
Moderate to high, but complete recovery without any residual neurological deficit is not always guaranteed, especially if nerve damage occurred prior to treatment
Underlying Disease Risk
Low for sporadic cases; significantly higher if associated with Neurofibromatosis type 2 (NF2), where multiple schwannomas can occur